Remove Gene Sequencing Remove Immune Response Remove Licensing
article thumbnail

Medicago, GSK’s plant-made COVID jab clears phase 2

pharmaphorum

.” The interim phase 2 results show that two doses of the plant-derived jab stimulated neutralising antibody levels that are around 10 times higher than those in a panel of sera from patients recovering from COVID-19, with a similar response seen in adults and the elderly.